TipRanks (Fri, 20-Mar 6:30 AM ET)
TipRanks (Mon, 16-Mar 12:15 AM ET)
Market Chameleon (Thu, 12-Mar 5:01 AM ET)
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026
Business Wire (Thu, 12-Mar 6:30 AM ET)
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
Business Wire (Thu, 26-Feb 6:30 AM ET)
Business Wire (Tue, 24-Feb 6:39 AM ET)
Compass Pathways Secures $150 Million to Advance Late-Stage Trials—What’s the Strategic Impact?
Market Chameleon (Thu, 19-Feb 2:11 AM ET)
Compass Pathways Announces Pricing of $150 Million Public Offering
Business Wire (Wed, 18-Feb 8:18 PM ET)
Market Chameleon (Wed, 18-Feb 5:34 AM ET)
Compass Pathways Launches Proposed $150.0 Million Public Offering
Business Wire (Tue, 17-Feb 4:06 PM ET)
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.
As of March 20, 2026, CMPS stock price declined to $5.47 with 1,408,173 million shares trading.
CMPS has a beta of 0.97, meaning it tends to be less sensitive to market movements. CMPS has a correlation of 0.03 to the broad based SPY ETF.
CMPS has a market cap of $620.94 million. This is considered a Small Cap stock.
In the last 3 years, CMPS traded as high as $12.75 and as low as $2.25.
The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, GWX, BBC.
CMPS has outperformed the market in the last year with a return of +78.8%, while the SPY ETF gained +15.4%. However, in the most recent history, CMPS shares have underperformed the stock market with its stock returning -14.1% in the last 3 month period and -19.3% for the last 2 week period, while SPY has returned -4.9% and -5.0%, respectively.
CMPS support price is $5.45 and resistance is $6.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.